Rodec Pharma Share Price Today

Rodec Pharma Limited Unlisted Shares - Company Overview

Rodec Pharma Limited is a Public company incorporated on 18 Nov 1997. It is classified as Non-government company and is registered at Registrar of Companies, Delhi. Its authorized share capital is Rs. 2500000.00 and its paid up capital is Rs. 22,58,48,000

Rodec Pharma Limited is an Indian pharmaceutical company established in 1997, primarily engaged in the veterinary healthcare segment. The company focuses on the formulation, development, marketing and distribution of veterinary medicines, animal healthcare products and nutritional supplements. Its product portfolio caters to the healthcare requirements of livestock, poultry and other animals. The company serves veterinarians, farmers, dairy operators, government institutions and private veterinary organisations across India. Headquartered in Ghaziabad, Uttar Pradesh, Rodec Pharma has developed a presence in the animal healthcare industry through its focus on affordable, quality veterinary products.

Rodec Pharma Limited Share Price, Share Details as of March 31, 2025

Rodec Pharma Limited Incorporation Details

Rodec Pharma Limited Board of Directors

Rodec Pharma Limited Principal Business Activities

FAQs on Rodec Pharma Limited

1. What is Rodec Pharma Limited?

Answer: Rodec Pharma Limited is an Indian animal healthcare and veterinary pharmaceutical company engaged in manufacturing animal feed supplements and marketing veterinary medicines and nutritional products for livestock.

2. What is the face value of Rodec Pharma shares?

Answer: The face value of Rodec Pharma equity shares is ₹10 per share.

3. How can I buy Rodec Pharma unlisted shares through WWIPL?

Answer: Investors can complete KYC formalities, confirm pricing and availability, make payment, and receive shares directly into their Demat account through WWIPL.

4. Why should I buy Rodec Pharma shares through WWIPL?

Answer: WWIPL provides access to unlisted share transactions with transparent pricing, secure settlements, and dedicated transaction support.

5. Is investing in Rodec Pharma a good idea?

Answer: Investors should evaluate the company's financial performance, revenue growth, profitability, manufacturing capabilities, product portfolio, valuation, and growth prospects before making an investment decision.

6. What is the primary business of Rodec Pharma?

Answer: Rodec Pharma primarily operates in the animal healthcare sector, manufacturing animal feed supplements and marketing veterinary pharmaceutical drugs and nutritional products for livestock.

7. What products does Rodec Pharma offer?

Answer: The company's product portfolio includes veterinary medicines, animal feed supplements, nutritional formulations, and healthcare products designed to address the health and nutritional requirements of livestock.

8. What factors influence the valuation of Rodec Pharma shares?

Answer: Revenue growth, profitability, manufacturing capacity, product demand, distribution network, operating margins, livestock healthcare demand, and business expansion can influence valuation.

9. What documents are required to buy Rodec Pharma shares through WWIPL?

Answer: Investors generally need PAN, Aadhaar, Client Master Report (CMR), and bank account details to complete the transaction.

10. Are Rodec Pharma shares transferred in Demat form?

Answer: Yes. Shares purchased through WWIPL are transferred directly into the investor's Demat account, subject to applicable settlement procedures.

11. Can I sell my Rodec Pharma shares through WWIPL?

Answer: Yes. WWIPL facilitates buying and selling of unlisted shares, subject to market demand, buyer availability, and applicable transaction conditions.

12. What are the key growth drivers for Rodec Pharma?

Answer: Increasing demand for veterinary healthcare, growth in India's livestock and dairy sectors, rising awareness of animal nutrition, expansion of distribution networks, and demand for quality veterinary medicines can support the company's growth.

13. What risks should investors consider before investing in Rodec Pharma?

Answer: Investors should consider risks related to regulatory compliance, raw material costs, competition, product quality, distribution, customer concentration, working capital, and liquidity of unlisted shares.

14. Why are HNIs interested in Rodec Pharma's unlisted shares?

Answer: Investors may consider Rodec Pharma for exposure to India's growing animal healthcare and veterinary pharmaceutical industry, supported by demand for livestock medicines and nutritional supplements.

15. How does WWIPL help investors track Rodec Pharma investments?

Answer: WWIPL provides company information, transaction assistance, pricing updates, and support related to buying and selling unlisted shares.